Case number 1:24-cv-00396
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 21, 2024 | 15 | Return of Service Executed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. Hetero Labs Limited served on 6/20/2024, answer due 7/11/2024; Hetero Labs Limited Unit-V served on 6/20/2024, answer due 7/11/2024; Hetero USA Inc. served on 6/20/2024, answer due 7/11/2024. (Attachments: # 1 Proof of Service for Hetero Labs Limited, # 2 Proof of Service for Hetero Labs Limited Unit-V)(Zare, Maliheh) (Entered: 06/21/2024) (0) |
| May 6, 2024 | 14 | NOTICE of Appearance by Maliheh Zare on behalf of Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited (Zare, Maliheh) (Entered: 05/06/2024) (2) |
| May 1, 2024 | 13 | NOTICE requesting Clerk to remove Alexandra Joyce as co-counsel. Reason for request: No Longer Counsel of Record. (Joyce, Alexandra) (Entered: 05/01/2024) (2) |
| Apr 11, 2024 | N/A | Pro Hac Vice Attorney Chad J. Peterman for Arbor Pharmaceuticals, LLC,and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/11/2024) (0) |
| Apr 11, 2024 | N/A | Pro Hac Vice Attorney Sarah E. Spencer for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/11/2024) (0) |
| Apr 11, 2024 | N/A | Pro Hac Vice Attorney Christopher P. Hill for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/11/2024) (0) |
| Apr 11, 2024 | N/A | Pro Hac Vice Attorney Michael F. Werno for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/11/2024) (0) |
| Apr 8, 2024 | N/A | Pro Hac Vice Attorney Zhiqiang Liu for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (vfm) (Entered: 04/08/2024) (0) |
| Apr 8, 2024 | N/A | Pro Hac Vice Attorney Bruce M. Wexler for Arbor Pharmaceuticals, LLC and Azurity Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 04/08/2024) (0) |
| Apr 5, 2024 | 9 | MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu - filed by Takeda Pharmaceutical Company Limited. (Attachments: # 1 Certifications for William F. Cavanaugh, Jr. and Zhiqiang Liu)(Joyce, Alexandra) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | 10 | Pro Hac Vice Fee - Credit Card Payment received for William F. Cavanaugh, Jr. and Zhiqiang Liu. ( re 9 MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu )( Payment of $ 100, receipt number ADEDC-4378089).(Joyce, Alexandra) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | N/A | SO ORDERED re 9 MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu filed by Takeda Pharmaceutical Company Limited. ORDERED by Judge Maryellen Noreika on 4/5/2024. (dlw) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | 11 | MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno, and Sarah E. Spencer - filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc.. (Attachments: # 1 Certifications for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno, and Sarah E. Spencer)(Joyce, Alexandra) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | 12 | Pro Hac Vice Fee - Credit Card Payment received for Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno, and Sarah E. Spencer. ( re 11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno, and Sarah E. Spencer )( Payment of $ 250, receipt number ADEDC-4378251).(Joyce, Alexandra) (Entered: 04/05/2024) (0) |
| Apr 5, 2024 | N/A | SO ORDERED re 11 MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, Christopher P. Hill, Michael F. Werno, and Sarah E. Spencer filed by Arbor Pharmaceuticals, LLC, Azurity Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 4/5/2024. (dlw) (Entered: 04/05/2024) (0) |
| Apr 3, 2024 | N/A | Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) (Entered: 04/03/2024) (0) |
| Mar 28, 2024 | 1 | COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. ( Filing fee $ 405, receipt number ADEDC-4372453.) - filed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet) (vfm) (Entered: 03/28/2024) (0) |
| Mar 28, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 03/28/2024) (3) |
| Mar 28, 2024 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/16/2024. Date of Expiration of Patent: 03/26/2028.Thirty Month Stay Deadline: 8/16/2026. (vfm) (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,936. (vfm) (Entered: 03/28/2024) (1) |
| Mar 28, 2024 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc., Other Affiliate Azurity Pharmaceuticals, Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (vfm) (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc.. (vfm) (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Master Trust Bank of Japan, Ltd. for Takeda Pharmaceutical Company Limited filed by Takeda Pharmaceutical Company Limited. (vfm) (Entered: 03/28/2024) (2) |
| Mar 28, 2024 | 8 | Summons Issued as to Hetero Labs Limited on 3/28/2024; Hetero Labs Limited Unit-V on 3/28/2024; Hetero USA Inc. on 3/28/2024. (Attachments: # 1 Summons Issued Hetero USA Inc, # 2 Summons Issued Hetero Labs Limited) (vfm) (Entered: 03/28/2024) (0) |
